Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B-cell depletion in autoimmune diseases
Georg Schett, György Nagy, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225727
Closed Access | Times Cited: 10

Showing 10 citing articles:

Weal and woe of interleukin-18 in the T cell therapy of cancer
Christoph Kessel, Claudia Rössig, Hinrich Abken
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010545-e010545
Open Access
Clinical application of biological agents in rheumatoid arthritis
Lianying Cheng, Xiaofeng Rong
Transplant Immunology (2025), pp. 102187-102187
Open Access
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Pharmacotherapy of autoimmune rheumatic diseases – from monoclonal antibodies to CAR T cells: 20 years later
Е. Л. Насонов, A. G. Rumyantsev, Samsonov MIu
Rheumatology Science and Practice (2024) Vol. 62, Iss. 3, pp. 262-279
Open Access | Times Cited: 2
Sustained drug-free remission in rheumatoid arthritis associated with diffuse large B-cell lymphoma following tandem CD20-CD19-directed non-cryopreserved CAR-T cell therapy using zamtocabtagene autoleucel
Dolóresz Szabó, Alexandra Balogh, László Gopcsa, et al.
RMD Open (2024) Vol. 10, Iss. 4, pp. e004727-e004727
Open Access | Times Cited: 1
The indications and safety of rituximab for the treatment of pediatric autoimmune diseases: a single-center retrospective study
Mohammed Alsubaie, Abdulrahman B Bahkali, Saeed A Alhudaifi, et al.
Translational Pediatrics (2024) Vol. 13, Iss. 10, pp. 1696-1702
Open Access | Times Cited: 1
CAR T-cell perspectives in lupus – Authors' reply
Georg Schett, Andréas Mackensen, Dimitrios Mougiakakos
The Lancet (2024) Vol. 404, Iss. 10450, pp. 336-337
Closed Access
Releasing our model T – chimeric antigen receptor (CAR) T-cells for autoimmune indications
Holly Wobma, Joyce C. Chang, Susan E. Prockop
Current Opinion in Rheumatology (2024)
Closed Access
Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation
Xinzhan Jiang, Hongyu Zhang, Yongtao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?
Jérôme Avouac, Marc Scherlinger
BioDrugs (2024)
Closed Access
Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome
Jonathan Wickel, Ulf Schnetzke, Anne Sayer-Klink, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101794-101794
Open Access
Page 1

Scroll to top